Clinical Trial Update: Branched-chain Aminoacids in Sleep Apnea Syndromes (ARSAS) [Phase 3]

View source ↗

Summary

Phase 3 trial of branched-chain amino acids for sleep apnea was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sleep Apnea

Drugs mentioned

• branched-chain amino acids (branched-chain amino acids)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Sleep Apnea | Phase 3 | Status: WITHDRAWN